Consultations

Newswire – EU: The European Commission has published a public consultation (closes on 10 July 2010) on Short Selling & Credit Default Swaps. The purpose of the document is to consult market participants, regulators & other stakeholders on the options being considered by the Commission services for a forthcoming legislative proposal dealing with potential risks arising from short selling and Credit Default Swaps.
 
Short selling is the sale of a security that the seller does not own, with the intention of buying back an identical security at a later point in time in order to be able to deliver the security.  The Commission believes that working towards a more harmonised regime will increase the resilience & stability of financial markets in the EU.
Press release ~ Consultation
 
WAG: People across Wales are being asked their views on how to encourage more people to use the internet.

The move is part of the consultation for the Welsh Assembly Government’s Digital Inclusion Framework which aims to help people gain the skills & confidence to get online. Social Justice Minister, Carl Sargeant, has called on private, public & third sector organisations, as well the general public, to get involved in the consultation process (closes 9 September 2010).
Press release ~ Delivering digital inclusion - A strategic framework for Wales ~ Digital inclusion
 
NICE: All children & young people are entitled to high-quality education about sex, relationships & alcohol to help them make responsible decisions and acquire the skills & confidence to delay sex until they are ready.  Research suggests effective sex, relationships & alcohol education can help a child make responsible, healthy and safe choices, and improve their performance at school.
 
In draft guidance, issued for public consultation (closes on 15 July 2010), NICE recommends that children from primary school age upwards are given sex & relationships education that is appropriate to the maturity of the pupils, sensitive to diverse cultural, faith & family perspectives and based on an understanding of their needs.  

Only stakeholders can comment formally on consultations, but organisations can register to be a stakeholder at anytime during this process.
Press release ~ Consultation on draft guidance ~ PSHE: additional consultation on the evidence ~ Become a stakeholder
 
NICE: In preliminary draft guidance published last week, a new treatment for ovarian cancer is not recommended for NHS use because the manufacturer did not submit sufficient evidence that the drug benefits patients more than the most widely-used NHS treatments.  

The National Institute for Health and Clinical Excellence’s (NICE) preliminary guidance is now available for public consultation until 9 July 2010.
Press release ~ Ovarian cancer (relapsed) - trabectedin ~ Trabectedin for the treatment of advanced soft tissue sarcoma
 
NICE: The National Institute for Health and Clinical Excellence (NICE) has opened its consultation (closes on 10 September 2010) on the proposed process & methods guides for its Evaluation Pathway Programme for Medical Technologies.
Press release ~ Evaluation Pathway Programme for Medical Technologies
 
NICE: The Postmenopausal women who are at increased risk of osteoporotic fractures should be treated with denosumab if treatment with currently available oral bisphosphonates is unsuitable, according to draft guidance published by the National Institute for Health and Clinical Excellence (NICE). This Draft guidance has been issued for consultation (closes on 9 July 2010). 
Press release ~ Osteoporotic fractures - denosumab
 
EHRC: The Equality and Human Rights Commission is investigating whether public bodies & public transport providers are fulfilling their legal obligations to prevent disabled people from being harassed.  

Councils, police forces, schools and other public bodies as well as bus, train companies and other public transport providers found to be failing in their duties could face enforcement action – See ‘In the News’ section for more information.
Facing the Future...find out more